Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1260590-51-9 | MDL No. : | MFCD14706832 |
Formula : | C13H20ClN5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CJRKOJYCZNKFRI-XQKZEKTMSA-N |
M.W : | 281.78 | Pubchem ID : | 72206804 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.54 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 83.7 |
TPSA : | 56.84 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.26 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.48 |
Log Po/w (WLOGP) : | 1.81 |
Log Po/w (MLOGP) : | 1.56 |
Log Po/w (SILICOS-IT) : | 1.34 |
Consensus Log Po/w : | 1.44 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.37 |
Solubility : | 0.121 mg/ml ; 0.000429 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.32 |
Solubility : | 0.135 mg/ml ; 0.00048 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.63 |
Solubility : | 0.0655 mg/ml ; 0.000232 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.06 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: sodium hydroxide / dimethyl sulfoxide; water / 2 h / 70 °C / Large scale 2: N-ethyl-N,N-diisopropylamine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol / butan-1-ol / 2 h / 40 °C / Large scale 3: trifluorormethanesulfonic acid / water; acetonitrile / 1 h / 10 - 68 °C / Large scale | ||
Multi-step reaction with 3 steps 1: sodium hydroxide / dimethyl sulfoxide; water / 2 h / 70 °C / Large scale 2: N-ethyl-N,N-diisopropylamine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol / dichloromethane / 2 h / 40 °C / Large scale 3: trifluorormethanesulfonic acid / water; acetonitrile / 1 h / 10 - 68 °C / Large scale | ||
Multi-step reaction with 3 steps 1: sodium hydroxide / dimethyl sulfoxide; water / 2 h / 70 °C / Large scale 2: N-ethyl-N,N-diisopropylamine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol / toluene / 2 h / 40 °C / Large scale 3: trifluorormethanesulfonic acid / water; acetonitrile / 1 h / 10 - 68 °C / Large scale |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: sodium hydroxide / dimethyl sulfoxide; water / 2 h / 70 °C / Large scale 2: N-ethyl-N,N-diisopropylamine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol / dichloromethane / 2 h / 40 °C / Large scale | ||
Multi-step reaction with 2 steps 1: sodium hydroxide / dimethyl sulfoxide; water / 2 h / 70 °C / Large scale 2: N-ethyl-N,N-diisopropylamine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol / toluene / 2 h / 40 °C / Large scale | ||
Multi-step reaction with 2 steps 1: sodium hydroxide / dimethyl sulfoxide; water / 2 h / 70 °C / Large scale 2: N-ethyl-N,N-diisopropylamine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol / butan-1-ol / 2 h / 40 °C / Large scale |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium hydroxide In water; dimethyl sulfoxide at 70℃; for 2h; Large scale; | 5a a. Add 10kg to the reaction kettleN-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride,40kg dimethyl sulfoxide, 15kg purified water, 1.5kg sodium hydroxide, heated to 70 ° C;After the reaction is completed, stirring and crystallization for 2 h, suction filtration, and drying to obtain a product a;The obtained product a was added to the reaction vessel, 50 kg of absolute ethanol was added, and the mixture was heated to 60 ° C until the product a was completely dissolved, and 0.5 kg of medicinal charcoal was added for decolorization for 15 minutes;Filtration while hot, collecting the filtrate, cooling to 10 ° C, stirring and crystallization for 2 h, suction filtration, drying,Obtaining the N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine; | |
With sodium sulfate; sodium hydroxide In dichloromethane for 4h; | 1.1 Step 1: Preparation of Intermediate 1 Dichloromethane (6.0 L) and SM-A (600.0 g, 2.13 mol) were sequentially placed in a 10 L reaction flask and stirred for 30 min.A 50% sodium hydroxide solution (204.4 g, 2.56 mol) was added to adjust the pH = 9-10.Anhydrous sodium sulfate (100.0 g, 0.70 mol) was added and stirred for 4 h.Filter by suction and the filter cake was washed with a small amount of dichloromethane. The filtrate was concentrated to dryness at 40 to 50 ° C.It was a white foamy solid and was used directly in the next reaction. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In butan-1-ol at 40℃; for 2h; Large scale; | 2a a. Add 10kg to the reaction kettleN-[(3R,4R)-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride,20 L of n-butanol, stirred to dissolve, adding 10.66 kg of ethyl cyanoacetate, 1.21 kg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride,5.1 kg of 1-hydroxybenzotriazole and 5.68 kg of N,N-diisopropylethylamine;The control temperature is 40±5°C, the reaction is 2h, and the reaction is completed by TLC;30 L of 1 wt% KHCO3 aqueous solution was added thereto, and the temperature was lowered to -2 ° C, stirred and decanted for 10 h, suction filtered, and dried.Obtaining crude tofacitinib; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.91 kg | With palladium 10% on activated carbon; hydrogen In water; isopropyl alcohol at 70℃; for 8h; Large scale; | 1 33.23 Kg of isopropanol and 4.70 Kg of purified water were added to a 100 L hydrogenation reactor.Add 4.7 Kg of N-((3R,4R)-1-phenyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrole [2,3-d]pyrimidine- 4-amine (IV),Add 0.47Kg of 10% wet palladium carbon;Nitrogen replacement,Hydrogen replacement;Keep the pressure 0.1~0.2MPa,The system was controlled at a temperature of 70 ± 5 ° C for 8 hours.Sampling HPLC to monitor the reaction,After the reaction is completed,Insulation 70 ± 5 ° C, hot pressure filter,Filtered to no solvent,Filter cakePropyl alcohol rinse,Combine the filtrate;The filtrate is under a vacuum of -0.08 to -0.1 MPa.Control the water bath temperature to 40 ~ 50 ° C,Concentrated to remove isopropanol and water,To no solvent evaporation;Then heat up to 60-70 ° C,Control the degree of vacuum -0.1 ~ -0.08MPa under reduced pressure,Concentrate to solvent free; add 7.38 Kg of isopropanol in water and concentrate to give a pale yellow solid. Whole batch to be concentratedAdd 18.42Kg isopropanol to the feed, start stirring for 2-3h; cool to 10-20 ° C, stir for 2-3 hours; centrifuge under nitrogen protection, filter cake with 4.70Kg isopropanol, centrifuge until substantially solvent free Out. Transfer the whole batch of wet product to a blast drying oven and dry at 45-55 ° C for 4-8 hours to obtain a white solid, ie N-methyl-N-((3R,4R)-4-methylpiperidine-3 -yl)-7H-pyrrolo[2,3-D]pyrimidin-4-amine hydrochloride (III), weighed a total of 2.91 Kg. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: hydrogen; palladium 10% on activated carbon / ethanol / Large scale 2: potassium carbonate / water / 8 h / 120 °C / Large scale 3: hydrogenchloride / ethanol; water / 3 h / 20 °C / Large scale |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2.56 kg | With hydrogenchloride In ethanol; water at 20℃; for 3h; Large scale; | 3-5 Example 3 The crude product was dissolved with 3 times the mass of ethanol, and then added dropwise to 5 times the volume of a 6 mol / L hydrochloric acid ethanol solution, and reacted at room temperature for 3 hours. A white solid precipitated, filtered with suction, and the filter cake was washed twice with ethanol to obtain The structural formula of N-methyl-N-((3R, 4R) -4-methylpiperidin-3-yl) -7H-pyrrolo [2,3-D] pyrimidin-4-amine hydrochloride is 2.56Kg. (V) The compound has a total yield of 90.8% in two steps, a chemical purity of> 99%, and an EE of> 99%. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.4% | Stage #1: ((3R,4R)-4-methylpiperidin-3-yl)-N-methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amine dihydrochloride; ethyl 2-cyanoacetate With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 40℃; for 6h; Stage #2: citric acid In water; acetonitrile at 0 - 10℃; for 2h; | 1.2; 2.2; 3.2 2) Synthesis of tofacitib citrate Add 26,9g (0.08mol) of compound 1,200ml of acetonitrile, 45.7g (0.3mol) of DBU, 27.1g (0.24mol) of ethyl cyanoacetate into the glass bottle, raise the temperature to 40C and react for 6h,Then add 50.4g (0.24mol) of citric acid monohydrate, 150ml of water, reduce the temperature to 0-10C, keep incubating for 2h, crystallization, filtration, and drying to obtain 38.9g of tofacitib citrate with a purity of 99.93%.Compound 1 was not detected (RRT0.3 is the impurity relative to the main peak time 0.3 on the liquid chromatogram), and the yield was 96.4%. The liquid chromatogram of the obtained tofacitib citrate is shown in Figure 3. |
[ 477600-73-0 ]
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.94
[ 1208319-26-9 ]
N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide
Similarity: 0.70
[ 1500-85-2 ]
7H-Pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.67
[ 1080467-50-0 ]
5-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.67
[ 1018441-16-1 ]
N-Methyl-1H-pyrrolo[2,3-b]pyridin-6-amine
Similarity: 0.67
[ 477600-73-0 ]
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.94
[ 1208319-26-9 ]
N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide
Similarity: 0.70
[ 1638760-44-7 ]
5-Methyl-7H-pyrrolo[2,3-d]pyrimidine
Similarity: 0.69
[ 1500-85-2 ]
7H-Pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.67
[ 1080467-50-0 ]
5-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.67
[ 477600-73-0 ]
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.94
[ 24867-26-3 ]
2,4-Diamino-6-piperidinopyrimidine
Similarity: 0.64
[ 69206-89-9 ]
6-(Piperidin-1-yl)pyrimidin-4-amine
Similarity: 0.59
[ 923036-30-0 ]
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Similarity: 0.58